Insulet Pre-Tax Profit Margin 2012-2026 | PODD
Current and historical pre-tax profit margin for Insulet (PODD) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Insulet pre-tax profit margin for the three months ending June 30, 2026 was .
| Insulet Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $3.05B | $0.50B | 16.21% |
| 2026-03-31 | $2.90B | $0.40B | 13.93% |
| 2025-12-31 | $2.71B | $0.34B | 12.52% |
| 2025-09-30 | $2.52B | $0.31B | 12.29% |
| 2025-06-30 | $2.36B | $0.27B | 11.44% |
| 2025-03-31 | $2.20B | $0.29B | 13.32% |
| 2024-12-31 | $2.07B | $0.30B | 14.47% |
| 2024-09-30 | $1.99B | $0.30B | 14.96% |
| 2024-06-30 | $1.87B | $0.27B | 14.30% |
| 2024-03-31 | $1.78B | $0.25B | 13.80% |
| 2023-12-31 | $1.70B | $0.22B | 12.72% |
| 2023-09-30 | $1.56B | $0.13B | 8.34% |
| 2023-06-30 | $1.47B | $0.07B | 4.77% |
| 2023-03-31 | $1.37B | $0.01B | 0.37% |
| 2022-12-31 | $1.31B | $0.01B | 0.69% |
| 2022-09-30 | $1.24B | $0.02B | 1.61% |
| 2022-06-30 | $1.18B | $0.04B | 3.48% |
| 2022-03-31 | $1.14B | $0.05B | 4.29% |
| 2021-12-31 | $1.10B | $0.02B | 1.82% |
| 2021-09-30 | $1.04B | $-0.03B | -3.09% |
| 2021-06-30 | $1.00B | $-0.03B | -3.42% |
| 2021-03-31 | $0.96B | $0.01B | 1.15% |
| 2020-12-31 | $0.90B | $0.01B | 0.88% |
| 2020-09-30 | $0.87B | $0.03B | 3.92% |
| 2020-06-30 | $0.83B | $0.02B | 2.67% |
| 2020-03-31 | $0.78B | $0.01B | 0.90% |
| 2019-12-31 | $0.74B | $0.02B | 2.03% |
| 2019-09-30 | $0.69B | $0.02B | 2.74% |
| 2019-06-30 | $0.65B | $0.02B | 3.06% |
| 2019-03-31 | $0.60B | $0.02B | 2.83% |
| 2018-12-31 | $0.56B | $0.01B | 1.06% |
| 2018-09-30 | $0.53B | $-0.01B | -2.26% |
| 2018-06-30 | $0.50B | $-0.02B | -3.19% |
| 2018-03-31 | $0.49B | $-0.02B | -4.72% |
| 2017-12-31 | $0.47B | $-0.03B | -5.81% |
| 2017-09-30 | $0.44B | $-0.03B | -6.62% |
| 2017-06-30 | $0.41B | $-0.03B | -7.30% |
| 2017-03-31 | $0.39B | $-0.03B | -6.70% |
| 2016-12-31 | $0.37B | $-0.03B | -7.36% |
| 2016-09-30 | $0.35B | $-0.03B | -9.80% |
| 2016-06-30 | $0.32B | $-0.05B | -15.17% |
| 2016-03-31 | $0.30B | $-0.06B | -20.88% |
| 2015-12-31 | $0.26B | $-0.06B | -23.11% |
| 2015-09-30 | $0.20B | $-0.05B | -24.10% |
| 2015-06-30 | $0.20B | $-0.04B | -20.10% |
| 2015-03-31 | $0.21B | $-0.05B | -24.76% |
| 2014-12-31 | $0.23B | $-0.05B | -20.78% |
| 2014-09-30 | $0.29B | $-0.05B | -17.19% |
| 2014-06-30 | $0.27B | $-0.06B | -21.77% |
| 2014-03-31 | $0.26B | $-0.04B | -15.44% |
| 2013-12-31 | $0.25B | $-0.05B | -18.22% |
| 2013-09-30 | $0.24B | $-0.05B | -22.03% |
| 2013-06-30 | $0.23B | $-0.04B | -18.70% |
| 2013-03-31 | $0.22B | $-0.05B | -21.27% |
| 2012-12-31 | $0.21B | $-0.05B | -24.06% |
| 2012-09-30 | $0.20B | $-0.06B | -27.36% |
| 2012-06-30 | $0.19B | $-0.06B | -29.84% |
| 2012-03-31 | $0.17B | $-0.06B | -36.05% |
| 2011-12-31 | $0.15B | $-0.06B | -37.50% |
| 2011-09-30 | $0.13B | $-0.06B | -48.12% |
| 2011-06-30 | $0.11B | $-0.06B | -54.87% |
| 2011-03-31 | $0.10B | $-0.06B | -54.81% |
| 2010-12-31 | $0.10B | $-0.06B | -62.89% |
| 2010-09-30 | $0.09B | $-0.06B | -62.92% |
| 2010-06-30 | $0.08B | $-0.06B | -73.49% |
| 2010-03-31 | $0.08B | $-0.07B | -89.33% |
| 2009-12-31 | $0.07B | $-0.07B | -110.61% |
| 2009-09-30 | $0.06B | $-0.09B | -148.28% |
| 2009-06-30 | $0.05B | $-0.09B | -185.71% |
| 2009-03-31 | $0.04B | $-0.10B | -231.71% |
| 2008-12-31 | $0.04B | $-0.10B | -263.89% |
| 2008-09-30 | $0.03B | $-0.08B | -292.86% |
| 2008-06-30 | $0.02B | $-0.07B | -336.36% |
| 2008-03-31 | $0.02B | $-0.06B | -350.00% |
| 2007-12-31 | $0.01B | $-0.06B | -423.08% |
| 2007-09-30 | $0.01B | $-0.05B | -454.55% |
| 2007-06-30 | $0.01B | $-0.05B | -562.50% |
| 2007-03-31 | $0.01B | $-0.04B | -683.33% |
| 2006-12-31 | $0.00B | $-0.04B | -900.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $9.557B | $2.708B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |